In-vitro Inflammatory Bowel Disease Diagnostic Market

Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn?s disease. Ulcerative colitis is a long-term medical indication that causes inflammation and sores in the inner lining of colon and rectum. Crohn?s disease is part of inflammatory bowel disease that causes inflammation to any part of gastrointestinal tract, right from mouth to small intestine and anus. The exact cause of inflammatory bowel diseases is not known; however, autoimmune disorders, genetic factors, and lifestyle changes are thought to cause the symptoms of inflammatory bowel diseases in an individual .Common symptoms of inflammatory bowel diseases include diarrhea, abdominal pain & cramps, constipation, rectal bleeding, weight loss, and fever. Inflammatory bowel diseases (IBD) affect men and women equally and is more commonly observed in developed countries in the West than developing and underdeveloped countries. There is no single test that can diagnose the inflammatory bowel disease. However, the laboratory tests primarily involve blood test, fecal test, and genetic test. The laboratory tests are performed in conjunction with other screening tests such as CT-Scan, colonoscopy, endoscopy, and MRI screening.

In-vitro Inflammatory Bowel Disease Diagnostic Market contains market size and forecasts of In-vitro Inflammatory Bowel Disease Diagnostic in Global, including the following market information:

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In-vitro Inflammatory Bowel Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Assays/Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In-vitro Inflammatory Bowel Disease Diagnostic include DiaSorin S.p.A, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott, Quidel Corporation, American Laboratory Products Company (ALPCO), Certest Biotec SL. and Biosystems S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the In-vitro Inflammatory Bowel Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)

Assays/Biomarker

Analyzers

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)

Diagnostic Laboratories

Hospitals

Research Institutes

Global In-vitro Inflammatory Bowel Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In-vitro Inflammatory Bowel Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In-vitro Inflammatory Bowel Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies In-vitro Inflammatory Bowel Disease Diagnostic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

DiaSorin S.p.A

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

Abbott

Quidel Corporation

American Laboratory Products Company (ALPCO)

Certest Biotec SL.

Biosystems S.A.